[AKER] Akers Biosciences Inc
Overview
Type of security: Stock
Sector: Health Care
Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
Market Capitalization: 13.55 M
Exchange: NASDAQ
The data is delayed by 15 minutes.
Strongest Trends Summary For AKER
AKER is in the medium-term down -63% in 5 months. In the long-term up 181% above S&P in 1 year and down -90% below S&P in 7 years.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Akers Biosciences, Inc., together with its subsidiaries, focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. The company offers BreathScan/CHUBE, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor weight loss; VIVO for the measurement of biological markers for oxidative stress that relates to cellular damage non-invasively; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid assay for detecting heparin-induced thrombocytopenia antibodies; seraSTAT, a device to separate rapid blood cells; and Tri-Cholesterol ?Check? to estimate high density lipoprotein cholesterol and low density lipo protein levels. It is also involved in the development of Breath Ketone ?Check?, a disposable breath ketone device for diabetic monitoring, and management of senile dementia and alzheimers disease patients; Breath PulmoHe
Fundamental Ratios
| Shares Outstanding | 5.42 M | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | |||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | -62.31% | Sales Growth - Q/Q | -64.75% | P/E | ||
| P/E To EPS Growth | P/S | 3.6 | P/BV | 0.95 | Price/Cash Per Share | 1.61 | |
| Price/Free Cash Flow | -3.47 | ROA | -25.08% | ROE | -27.12% | ROI | |
| Current Ratio | 10.26 | Quick Ratio | 9.42 | Long Term Debt/Equity | Debt Ratio | 0.08 | |
| Gross Margin | 78.85% | Operating Margin | -105% | Net Profit Margin | -102.39% | Dividend Payout Ratio | |
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | Cash From Investing Activities | Cash From Operating Activities | 1.12 M | Gross Profit | 280 K | ||
| Net Profit | -1.24 M | Operating Profit | -1.36 M | Total Assets | 15.36 M | Total Current Assets | 11.81 M |
| Total Current Liabilities | 1.15 M | Total Debt | Total Liabilities | 1.15 M | Total Revenue | 510 K |
Technical Data
| High 52 week | 3.76 | Low 52 week | 0.13 | Last close | 1.47 | Last change | 13.08% |
| RSI | 77.33 | Average true range | 0.22 | Beta | 1.44 | Volume | 16.56 K |
| Simple moving average 20 days | 32.34% | Simple moving average 50 days | -3.02% | Simple moving average 200 days | 22.91% |
Performance Data
| Performance Week | 2.08% | Performance Month | 26.72% | Performance Quart | -50.34% | Performance Half | 208.69% |
| Performance Year | 91.16% | Performance Year-to-date | 30.09% | Volatility daily | 12.57% | Volatility weekly | 28.11% |
| Volatility monthly | 57.61% | Volatility yearly | 199.57% | Relative Volume | 179.39% | Average Volume | 2.17 M |
| New High | New Low |
News
2019-02-19 08:01:57 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-02-16 08:05:31 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-02-08 08:05:39 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-02-05 08:05:45 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-01-31 08:04:57 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-01-17 08:02:09 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-01-15 08:04:54 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2019-01-09 08:05:01 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-12-31 10:50:00 | 4 Healthcare Stocks That Are Raising Eyebrows
2018-12-28 11:45:00 | These 4 Healthcare Stocks Are Heating Up
2018-11-29 08:06:42 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-11-20 15:09:56 | This Tiny Biotech Firm Is Weighing An Entrance Into Cannabis
2018-11-20 08:06:47 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-11-20 06:50:00 | Today’s Research Reports on Stocks to Watch: Akers Biosciences and Align Technology
2018-11-19 16:48:05 | [$$] Biotech Learns the Magic Word
2018-11-19 14:34:49 | Apple shares down after cutting production orders for all three iphone models
2018-11-19 13:59:00 | Failing biotech company mentions pot business, stock soars 70%
2018-11-19 10:23:45 | South Jersey medical device firm exploring cannabis industry combination
2018-11-19 09:01:06 | Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry
2018-11-15 07:00:00 | Akers Biosciences Announces Q3 2018 Earnings
2018-11-07 13:16:43 | South Jersey medical-device company exploring 'strategic alternatives'
2018-11-07 09:15:00 | Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
2018-10-26 08:05:25 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-10-25 08:06:14 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-10-23 08:06:46 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-10-23 07:40:00 | Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA — Emerging Consolidated Expectations, Analyst Ratings
2018-10-13 08:06:32 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-10-08 12:08:10 | South Jersey medical device company makes CEO switch, settles lawsuit
2018-10-08 02:00:00 | Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
2018-09-29 08:05:20 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-09-27 08:06:48 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-09-25 08:06:36 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-09-20 08:05:48 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-08-14 16:18:00 | Akers Biosciences Announces Q2 and H1 2018 Earnings
2018-08-14 08:06:55 | See what the IHS Markit Score report has to say about Akers Biosciences Inc.
2018-08-13 12:05:00 | DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2018-08-13 10:21:00 | FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. AKER & Lead Plaintiff Deadline: August 13, 2018
2018-08-12 21:40:00 | DEADLINE MONDAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2018-08-12 11:00:00 | AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case – AKER
2018-08-11 09:00:00 | ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER
2018-08-11 08:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER
2018-08-10 19:42:00 | The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. AKER
2018-08-10 12:50:00 | AUGUST 13 DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
2018-08-09 18:06:20 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E, Akers Biosciences, and UNUM and Encourages Investors to Contact the Firm
2018-08-09 17:20:00 | August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. AKER
2018-08-09 14:57:00 | IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
2018-08-08 19:11:00 | Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akers Biosciences, Inc. Investors